Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKZF2 | Q9UKS7 | 12/20 | 0.41 |
| ▸ | CRBN | Q96SW2 | 7/20 | 0.41 |
| ▸ | CSNK1A1 | P48729 | 3/20 | 0.38 |
| ▸ | GSPT1 | P15170 | 1/20 | 0.37 |
| ▸ | SALL4 | Q9UJQ4 | 1/20 | 0.37 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31546718 | 0.89 | CRBN (0.42) | IKZF2CRBNCSNK1A1GSPT1SALL4 | |
| SCHEMBL20231897 | 0.79 | CRBN (0.53) | IKZF2CRBNCSNK1A1GSPT1IKZF3 | |
| SCHEMBL30906200 | 0.78 | CRBN (0.48) | IKZF2CRBNCSNK1A1ESR1 | |
| SCHEMBL30906241 | 0.77 | CRBN (0.47) | IKZF2CRBNCSNK1A1GSPT1IKZF3 | |
| SCHEMBL30906282 | 0.77 | CRBN (0.52) | IKZF2CRBNESR1 | |
| SCHEMBL30942475 | 0.76 | IKZF2 (0.51) | IKZF2CRBNCSNK1A1GSPT1IKZF3 | |
| SCHEMBL20235032 | 0.76 | CRBN (0.49) | IKZF2CRBNCSNK1A1GSPT1SALL4 | |
| SCHEMBL27302318 | 0.76 | IKZF2 (0.51) | IKZF2CRBNCSNK1A1GSPT1IKZF3 | |
| SCHEMBL25581068 | 0.76 | CRBN (0.54) | IKZF2CRBNCSNK1A1GSPT1IKZF3 | |
| SCHEMBL31546771 | 0.76 | CRBN (0.48) | IKZF2CRBNCSNK1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025076285-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | DELPHIA THERAPEUTICS, INC. (US) | 2025-04-10 | — | — | WO | disclosed |